Selenium-mediated inhibition of transcription factor NF-κB and HIV-1 LTR promoter activity

Archives of Toxicology

Volumn 70, Issue 5, 1996, Pages 277-283

  Makropoulos, Vassili ^a   Brüning, Thomas ^a   Schulze Osthoff, Klaus ^b  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Glutathione peroxidase; HIV 1; NF B; Reactive oxygen intermediates; Selenium

Indexed keywords

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SELENIUM; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL;

CELL LINE; CELL MOVEMENT; GENE EXPRESSION REGULATION, VIRAL; GLUTATHIONE PEROXIDASE; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LUCIFERASES; NF-KAPPA B; PLASMIDS; REACTIVE OXYGEN SPECIES; SELENIUM; T-LYMPHOCYTES; TRANSFECTION;

EID: 0030055822     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050274     Document Type: Article

References (43)

1. Ameisen JC (1994) Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS 8: 1197-1213
2. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochem Biophys Res Commun 1072: 129-157
3. Baeuerle PA, Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179
4. Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastangeli A, Saltini C, Cantin AM, Crystal RG (1989) Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2: 1294-1296
5. Buttke TM, Sandström PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7-10
6. Combs GF, Levander JE, Spallholz OA, Oldfield JE (1987) Selenium in biology and medicine. Avi Book, Van Nostrand-Reinhold Company, New York
7. Deng T, Karin M (1993) JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev 7: 479-490
8. Devary Y, Rosette C, DiDonato JA, Karin M (1993) NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science 261: 1442-1445
9. Dröge W, Eck H-P, Mihm S (1992) HIV-induced cysteine deficiency and T-cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol Today 13: 211-213
10. Dröge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck H-P, Roth S, Gmünder H (1994) Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 14: 1131-1138
11. Dworkin BM, Rosenthal WS, Wormser GP (1988) Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and AIDS-related complex. Biol Trace Elem Res 15: 167-177
12. Eck H-P, Gmünder H, Hartmann H, Petzoldt D, Daniel V, Dröge W (1989) Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe-Seyler 370: 101-108
13. Flohé L, Gunzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105: 114-121
14. Grilli M, Chiu JJ-S, Lenardo MJ (1993) NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 143: 1-62
15. Halliwell B, Gutteridge JMC (1990) The role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186: 1-85
16. Kabelic T, Kinter A, Poli G, Anderson ME, Meister A, Fauci AS (1991) Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester and N-acetylcysteine. Proc Natl Acad Sci USA 88: 986-990
17. Legrand-Poels S, Vaira D, Pincemail J, Van de Vorst A, Piette J (1990) Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retroviruses 6: 1389-1397
18. Los M, Dröge W, Stricker K, Baeuerle PA, Schulze-Osthoff K (1995a) Hydrogen peroxide as a potent activator of T-lymphocyte functions. Eur J Immunol 25: 159-165
19. Los M, Schenk H, Hexel K, Baeuerle PA, Dröge W, Schulze-Osthoff K (1995b) IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 14: 3731-3740
20. Mannervik B (1985) Glutathione peroxidase. Methods Enzymol 113: 490-495
21. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as a secondary antioxidant-responsive factor. EMBO J 12: 2005-2015
22. Mihm S, Ennen J, Pessara U, Kurth R, Dröge W (1991) Inhibition of HIV-replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 5: 497-503
23. Nabel G, Baltimore D (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713
24. Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J (1989) Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res 25: 89-96
25. Pahl HL, Baeuerle PA (1994) Oxygen and the control of gene expression. Bioessays 16: 497-502
26. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773-785
27. Sandström BE, Carlsson J, Marklund SL (1987) Variations among cultured cells in glutathione peroxidase activity in response to selenite supplementation. Biochim Biophys Acta 929: 148-153
28. Schenk H, Klein M, Ergdbrügger W, Dröge W, Schulze-Osthoff K (1994) Distinct effects of thioredoxin and other antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci USA 91: 1672-1676
29. Schmidt KN, Amstad P, Cerutti PA, Baeuerle PA (1995) The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem Biol 2: 13-22
30. Schrauzer GN, Sacher J (1994) Selenium in the maintainance and therapy of HIV-infected patients. Chem-Biol Interact 91: 199-205
31. Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-κB transcription factor and HIV-1. EMBO J 10: 2247
32. Schulze-Osthoff K, Baeuerle PA (1995) Redox regulation of gene expression. In: McCord JM (ed) Oxyradicals in medical biology. JAI Press, Greenwich (in press)
33. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacobs W, Fiers W (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267: 5317-5323
34. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 12: 3095-3104
35. Schulze-Osthoff K, Los M, Baeuerle PA (1995) Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem Pharmacol 50: 735-741
36. Schwarz O, Virelizier JL, Montagnier L, Hazan U (1990) A microtransfection method using the luciferase-encoding reporter gene for the asssay of human immunodeficiency virus LTR promoter activity. Gene 88: 197-205
37. Speier S, Bakker SS, Newberger PE (1985) Relationship between in vitro selenium supply, glutathione peroxidase activity, and phagocytic function in the HL-60 human myeloid line. J Biol Chem 260: 2268-2270
38. Staal FJT, Roederer M, Herzenberg LA, Herzenberg LA (1990) Intracellular thiols regulate activation of NF-κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 87: 9943-9947
39. Staal FJT, Roederer M, Raju PA, Anderson MT, Esa SW, Herzenberg LA, Herzenberg LA (1993) Antioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retroviruses 12: 167-172
40. Storz G, Tartaglia LA, Farr SB, Ames BN (1990) Bacterial defenses against oxidative stress. Trends Genet 6: 363-368
41. Suzuki YJ, Packer L (1993) Inhibition of NF-κB activation by vitamin E derivatives. Biochem Biophys Res Commun 193: 277-283
42. Traenckner EB-M, Wilk S, Baeuerle PA (1994) A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 13: 5433-5441
43. Traenckner EB-M, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA (1995) Phosphorylation of IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14: 2876-2883